Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Institute of Cancer Research
| Project | BRCA-DIRECT: A digital pathway for germline genetic testing in women with breast cancer |
|---|---|
| Description |
BRCA-DIRECT is an efficient NHS-embedded end-to-end clinical workflow involving a digital platform, saliva-sample postal pathway and genetic counsellor telephone hotline, the implementation of which means more patients with cancer can benefit from genetic testing for high-risk cancer genes like BRCA1 and BRCA2. |
| Funding | £ 1,902,636 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer |
| Health Innovation Network Partner | UCLPartners AHSN |
| Website | https://www.icr.ac.uk/our-research/researchers-and-teams/professor-clare-turnbull |
Modality LLP
| Project | Using a Novel Biomarker Approach to Transform Ovarian Cancer Diagnostic Pathways |
|---|---|
| Description |
A new diagnostic pathway for primary & secondary care using an algorithm that combines He4 and CA125 tests & evidence-based numerical thresholds to guide referral decisions. The aim of this project is to improve quality of life and save lives through early diagnosis of ovarian cancer. |
| Funding | £ 2,034,350 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer |
| Health Innovation Network Partner | West Midlands AHSN |
| Website | https://www.modalitycommunityservices.com/ |
The University of Manchester
| Project | Implementation of Elecsys® GAAD clinical algorithm for the early detection of Hepatocellular Carcinoma (HCC) in routine practice |
|---|---|
| Description |
With Roche Diagnostics Ltd, this 18-month project will explore the use of an innovative solution, called Elecsys®GAAD, to improve early Hepatocellular Carcinoma (HCC) detection. Elecsys®GAAD is a fully regulated, accurate test that combines blood tests with gender and age. If raised, it can suggest the presence of HCC. It will be used alongside routine surveillance tests to see if it can help in finding HCC earlier so patients have the best chance of surviving this cancer. |
| Funding | £ 1,006,075 |
| Competition | NHS Cancer Programme – Innovation Open Call – Competition 2 |
| Competition Date | February 2022 |
| Categories | Cancer |